A CBS News report released Monday questions whether arthroscopic knee surgery, a common orthopedic procedure in the United States, does more harm than good for patients with mild arthritis. The investigation quotes a surgeon who said, 'I don't know how I would defend this procedure,' highlighting growing skepticism among specialists.
Arthroscopic knee surgery, most often performed to trim or repair a torn meniscus, has become one of the most frequently performed orthopedic operations in the United States, with estimates exceeding 750,000 procedures annually according to the American Academy of Orthopaedic Surgeons (AAOS). The surgery is typically marketed as a minimally invasive solution that promises rapid recovery and return to activity, yet emerging research questions whether the benefits outweigh the potential drawbacks for patients with degenerative meniscal tears.
“I don't know how I would defend this procedure,” said the surgeon interviewed by CBS News, expressing frustration over the lack of clear evidence supporting routine arthroscopic meniscectomy for middle‑aged patients.
Knee Surgery Effectiveness Under Scrutiny
Recent randomized trials show that patients who undergo arthroscopic meniscectomy report similar pain relief and function scores after six months as those who complete supervised physical therapy alone. A 2023 meta‑analysis in the BMJ found no significant difference in postoperative knee‑function scores between surgical and non‑surgical groups (p=0.42). Longitudinal data suggest that up to 30% of patients experience persistent knee pain two years after surgery, raising doubts about the procedure’s lasting value.
Beyond limited efficacy, the procedure carries risks such as infection, blood clots, and accelerated cartilage wear, which can lead to earlier onset of osteoarthritis. Financial data indicate the average cost of arthroscopic knee surgery exceeds $15,000, whereas a course of physical therapy averages under $2,000. These factors have prompted insurers and health systems to reevaluate prior authorization policies for arthroscopic meniscectomy.
Orthopedic societies are reviewing current guidelines, and many experts anticipate a shift toward recommending conservative management as the first line of treatment for degenerative meniscal tears. Ongoing trials comparing surgery with structured exercise programs are expected to release results within the next 18 months, which could further influence clinical practice. Policy makers may also consider updating reimbursement models to favor non‑operative pathways when appropriate.
The meniscus is a C‑shaped cartilage pad that cushions the knee joint, distributing weight and stabilizing movement during activities such as walking, running, and jumping. Preserving meniscal tissue is crucial for long‑term joint health, as loss of this structure increases stress on articular cartilage and can hasten degenerative changes.
Key questions
- What is arthroscopic meniscectomy?
- Arthroscopic meniscectomy is a minimally invasive surgical procedure in which a surgeon uses a small camera and instruments inserted through tiny incisions to remove or repair damaged meniscal tissue in the knee joint.
- Are there effective alternatives to knee surgery for meniscal tears?
- Yes, structured physical therapy programs focusing on strengthening the muscles around the knee have been shown to provide comparable pain relief and functional improvement to surgery for many patients with degenerative meniscal tears.
